We are live on ! Find out more
Acadian Asset Management

Acadian Asset Management Portfolio holdings

AUM $70.5B
1-Year Est. Return 36%
This Fund
S&P 500
This Quarter Est. Return
-12.08%
1 Year Est. Return
+36%
3 Year Est. Return
+137.96%
5 Year Est. Return
+215.76%
10 Year Est. Return
+864.44%
AUM
$19.6B
AUM Growth
-$4.7B
Cap. Flow
-$1.27B
Cap. Flow %
-6.49%
Top 10 Hldgs %
18.42%
Holding
1,935
New
296
Increased
592
Reduced
625
Closed
249

Sector Composition

Rank Sector Weight
1 Technology 23.93%
2 Healthcare 17.38%
3 Consumer Staples 12.07%
4 Financials 9.42%
5 Materials 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNO icon
476
CNO Financial Group
CNO
$5.12B
$3.85M 0.02%
212,843
-66,323
-24% -$1.42M
OPBK icon
477
OP Bancorp
OPBK
$233M
$3.85M 0.02%
366,478
+55,290
+18% +$676K
ARC
478
DELISTED
ARC Document Solutions, Inc.
ARC
$3.81M 0.02%
1,449,258
+190,035
+15% +$619K
WRK
479
DELISTED
WestRock Company
WRK
$3.78M 0.02%
94,850
+50,825
+115% +$2.39M
HBIO icon
480
Harvard Bioscience
HBIO
$28.8M
$3.78M 0.02%
104,883
-1,848
-2% -$83.4K
ALLK
481
DELISTED
Allakos
ALLK
$3.71M 0.02%
1,186,213
+938,670
+379% +$3.51M
EPM icon
482
Evolution Petroleum
EPM
$134M
$3.71M 0.02%
680,147
+119,365
+21% +$803K
ERF
483
DELISTED
Enerplus Corporation
ERF
$3.7M 0.02%
280,308
+50,724
+22% +$699K
ALL icon
484
Allstate
ALL
$68.2B
$3.67M 0.02%
28,957
+5,940
+26% +$778K
DXLG icon
485
Destination XL Group
DXLG
$31.2M
$3.67M 0.02%
1,081,081
-36,153
-3% -$163K
VIR icon
486
Vir Biotechnology
VIR
$1.5B
$3.65M 0.02%
143,249
+135,531
+1,756% +$3.16M
IDA icon
487
Idacorp
IDA
$8.08B
$3.65M 0.02%
34,441
+21,683
+170% +$2.34M
CTVA icon
488
Corteva
CTVA
$51B
$3.64M 0.02%
67,239
-46,914
-41% -$2.72M
SRRK icon
489
Scholar Rock
SRRK
$6.32B
$3.6M 0.02%
+655,034
New +$4.7M
DTIL icon
490
Precision BioSciences
DTIL
$206M
$3.59M 0.02%
74,775
+41,210
+123% +$2.42M
APTV icon
491
Aptiv
APTV
$10.3B
$3.56M 0.02%
39,979
-9,289
-19% -$948K
IBN icon
492
ICICI Bank
IBN
$108B
$3.55M 0.02%
200,211
+166,668
+497% +$3.12M
CNCE
493
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$3.55M 0.02%
843,325
+49,219
+6% +$195K
CDW icon
494
CDW
CDW
$17.1B
$3.55M 0.02%
22,522
+21,942
+3,783% +$3.69M
GIII icon
495
G-III Apparel Group
GIII
$1.48B
$3.55M 0.02%
175,357
+74,976
+75% +$1.89M
NEE icon
496
NextEra Energy
NEE
$177B
$3.52M 0.02%
45,482
+36,148
+387% +$2.75M
ARAY icon
497
Accuray
ARAY
$34.9M
$3.52M 0.02%
1,797,629
+104,699
+6% +$261K
PAHC icon
498
Phibro Animal Health
PAHC
$1.39B
$3.51M 0.02%
183,348
-24,278
-12% -$460K
TA
499
DELISTED
TravelCenters of America LLC
TA
$3.46M 0.02%
100,512
+26,284
+35% +$976K
ARW icon
500
Arrow Electronics
ARW
$10.3B
$3.45M 0.02%
30,832
-27,989
-48% -$3.27M

Similar funds

Acadian Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, Acadian Asset Management held 1,935 positions worth $19.6B, down 19% from $24.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Acadian Asset Management withdrew a net $1.27B in Q2 2022, closing 249 positions and reducing 625 holdings. Its most notable exit was UBS Group, an estimated $189M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Acadian Asset Management opened a new position in HF Sinclair worth $77.4M.

  • Acadian Asset Management's largest Q2 2022 buy was HF Sinclair: 1,714,325 shares worth $77.4M.
  • Acadian Asset Management added most to GSK in Q2 2022, an estimated $324M increase.
  • Acadian Asset Management's biggest Q2 2022 reduction was Alphabet (Google) Class A, cutting an estimated $286M.
  • Acadian Asset Management fully exited UBS Group in Q2 2022, selling an estimated $189M.
  • Acadian Asset Management's ten largest holdings make up 18% of its $19.6B portfolio in Q2 2022.
  • Acadian Asset Management opened 296 new positions and closed 249 in Q2 2022.
  • Acadian Asset Management's portfolio value fell 19% quarter-over-quarter to $19.6B.

Based on Acadian Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.